CLEARWATER, Fla., March 30, 2006 (PRIMEZONE) -- Maui General Stores, dba Trinity BioGenics Corp. (OTCBB:MAUG), a research and development company focused on making adult stem cell procedures commercially available in conjunction with immune therapy, is pleased to announce it will be hosting a conference on the Future of Medicine and Surgery, in conjunction with The Stowe Foundation, which is to take place on April 1, 2006. Internationally renowned experts in the medical and life science field of stem cell therapy will attend the conference.
Trinity BioGenics, along with Lawrence R. Stowe, PhD., and Managing Director of The Stowe Foundation will host the Future of Medicine and Surgery conference. Dr. Stowe will present the therapeutic benefits of adult stem cells that can be achieved today and other notable speakers will include, Mr. Chip Dopson, president of Chisolm Biological Laboratory, Dr. Leonard Haimes, Clinical Expert in Internal Medicine, and Dr. Nikolaus Klehr, Medical Director of Institut fur Immunologie und Zellbiologic in Munich Germany.
The CEO of Trinity BioGenics, Lawrence Stowe, stated, "We are proud to headline this meeting, as it allows us to showcase and familiarize interested parties with our recent developments and accomplishments." Dr. Stowe continued to say, "It gives me great pleasure to present Adult Stem Cell technology in front of what will most certainly be a sold out event. adult stem cell research and development is the future of medicine, and Trinity BioGenics is wasting little time to capitalize on this rapidly expanding field."
About Trinity BioGenics Corp.
Trinity BioGenics Corp. works exclusively within the adult stem cell and biological medicine areas. The Company's proprietary protocols are advanced, and use specific processes to obtain desired results. The FDA classifies the Company's process as a unique blood product; therefore, it will be specific and unique to Trinity BioGenics Corp. Additionally, the Company's unique combination of immune therapy and adult stem cell treatments are like no other treatment experienced. The Company's adult stem cell protocol is under preparation for human clinical studies.
About The Stowe Foundation
The Stowe Foundation, with whom Trinity BioGenics holds a license to commercialize stem cell technology findings, is a 501c3 public charity dedicated to the study of the human immune system and the body's natural ability to heal itself from chronic illness. The Stowe Foundation is dedicated to validating the power of the immune system to heal the body and bringing the science of immune therapy into mainstream medicine.
The Maui General Store logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=1128